Jeremy Bender's Net Worth

$5.96 Million

Estimate Recalculated Nov 11, 2024 08:52AM EST

Who is Jeremy Bender?

Jeremy Bender has an estimated net worth of $5.96 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Fusion Pharmaceuticals Inc., and Mereo BioPharma Group plc.

SEC CIK

Jeremy Bender's CIK is 0001863107

Past Insider Trading and Trends

2024 was Jeremy Bender's most active year for acquiring shares with 13 total transactions. Jeremy Bender's most active month to acquire stocks was the month of January. 2022 was Jeremy Bender's most active year for disposing of shares, totalling 18 transactions. Jeremy Bender's most active month to dispose stocks was the month of April. 2022 saw Jeremy Bender paying a total of $0.00 for 468,248 shares, this is the most they've acquired in one year. In 2024 Jeremy Bender cashed out on 199,377 shares for a total of $1,807,933.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5

CHIEF EXECUTIVE OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.40%
9.32K
$14.00
-$149,524.39
98.93K
Aug 15 - Aug 16
Form 4
—
0
—
—
1.61M
Jul 2
Form 4
+1.89%
12.13K
$16.08
-$126,587.61
654.73K
May 15 - May 16
Form 4
-10.97%
-79.21K
$17.87
-$1,415,707.47
642.6K
Scheduled
May 1 - May 3
Form 4
+1.75%
12.38K
$15.25
-$116,114.28
721.81K
Feb 15 - Feb 16
Form 4
—
0
—
—
0
Jan 5
Form 4
+0.74%
5.21K
$11.69
-$36,320.83
709.43K
Nov 15 - Nov 16
Form 4
+0.76%
5.32K
$13.86
-$41,524.56
704.22K
Aug 15 - Aug 17
Form 4
—
0
—
—
2.22M
Jul 1
Form 4
+0.44%
5.21K
$13.12
-$40,731.62
1.18M
May 15 - May 16
Form 4
-1.05%
-12.50K
$20.01
-$250,113.75
1.17M
Scheduled
Mar 7
Form 4
+0.45%
5.29K
$19.57
-$59,149.61
1.19M
Feb 15 - Feb 16
Form 4
-1.05%
-12.50K
$22.00
-$274,987.50
1.18M
Scheduled
Jan 23
Form 4
—
0
—
—
0
Jan 17
Form 4
-1.04%
-12.50K
$20.32
-$253,968.75
1.19M
Scheduled
Dec 21
Form 4
-1.03%
-12.50K
$20.76
-$259,479.38
1.2M
Scheduled
Nov 21
Form 4
+0.17%
2.05K
$21.46
-$32,468.68
1.22M
Nov 15 - Nov 16
Form 4
-1.02%
-12.50K
$20.03
-$250,355.00
1.22M
Scheduled
Nov 1
Form 4
-1.01%
-12.50K
$20.05
-$250,646.25
1.23M
Scheduled
Oct 3
Form 4
-1.00%
-12.50K
$23.25
-$290,580.59
1.24M
Scheduled
Sep 1
Form 4
-1.00%
-12.50K
$23.25
-$290,580.59
1.24M
Scheduled
Sep 1
Form 4
+0.54%
6.68K
$24.31
-$97,312.93
1.25M
Aug 15 - Aug 16
Form 4
-0.99%
-12.50K
$20.00
-$250,021.25
1.25M
Scheduled
Aug 4
Form 4
-0.21%
-2.60K
$20.00
-$52,003.12
1.26M
Scheduled
Jul 18
Form 4
-0.14%
-1.79K
$20.00
-$35,900.00
1.26M
Scheduled
Jul 8
Form 4
-0.21%
-2.60K
$20.00
-$52,060.00
1.26M
Scheduled
Jul 1 - Jul 5
Form 4
—
0
—
—
0
Jan 18
Form 3
—
0
—
—
0
No matching records found

Fusion Pharmaceuticals Inc. (FUSN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Oct 16
Form 3
—
0
—
—
0
No matching records found

Mereo BioPharma Group plc (MREO) Snapshot price: $4.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
12.55K
$3.99
$50,074.50
12.55K
Jun 17
Form 4
—
0
—
—
0
Feb 8
Form 3
—
0
—
—
0
No matching records found